Cargando…
Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
The aim of this study was to assess chemotherapy treatment characteristics, neutropenic event occurrence and related risk factors in bone and soft tissue sarcoma patients in China. Knowledge of such risk factors aids healthcare providers in focusing resources on those who are at most risk and target...
Autores principales: | OUYANG, ZHENGXIAO, PENG, DAN, DHAKAL, DIBYA PURUSH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678576/ https://www.ncbi.nlm.nih.gov/pubmed/23760066 http://dx.doi.org/10.3892/ol.2013.1234 |
Ejemplares similares
-
Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020) -
Nomogram Predicting the Risk of Postoperative Major Wound Complication in Soft Tissue Sarcoma of the Trunk and Extremities after Preoperative Radiotherapy
por: Ouyang, Zhengxiao, et al.
Publicado: (2022) -
Paediatric bone and soft tissue sarcoma
por: Anderson, J
Publicado: (2007) -
Immunotherapy for Bone and Soft Tissue Sarcomas
por: Uehara, Takenori, et al.
Publicado: (2015) -
Pediatric bone and soft-tissue sarcomas
por: McCarville, Beth
Publicado: (2015)